A Dark Vector Cognition product

Item 16. Form 10-K Summary.

3K characters. Original on sec.gov ·

Item 16. Form 10-K Summary.

None.

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 22nd day of February, 2023.

M&T BANK CORPORATION
By:/s/ René F. Jones
René F. Jones Chairman of the Board and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
Principal Executive Officer:
/s/ René F. JonesChairman of the Board andFebruary 22, 2023
René F. JonesChief Executive Officer
Principal Financial Officer:
/s/ Darren J. KingSenior Executive Vice President andFebruary 22, 2023
Darren J. KingChief Financial Officer
Principal Accounting Officer:
/s/ Michael R. SpychalaExecutive Vice PresidentFebruary 22, 2023
Michael R. Spychalaand Controller
A majority of the board of directors:
/s/ John P. BarnesFebruary 22, 2023
John P. Barnes
/s/ Robert T. Brady Robert T. BradyFebruary 22, 2023
/s/ Carlton J. Charles Carlton J. CharlesFebruary 22, 2023
/s/ Jane ChwickFebruary 22, 2023
Jane Chwick
/s/ William F. Cruger, Jr.February 22, 2023
William F. Cruger, Jr.
/s/ T. Jefferson Cunningham IIIFebruary 22, 2023
T. Jefferson Cunningham III
/s/ Gary N. GeiselFebruary 22, 2023
Gary N. Geisel
/s/ Leslie V. GodridgeFebruary 22, 2023
Leslie V. Godridge
Richard H. Ledgett, Jr.February 22, 2023
/s/ Melinda R. Rich Melinda R. RichFebruary 22, 2023
/s/ Robert E. Sadler, Jr. Robert E. Sadler, Jr.February 22, 2023
/s/ Denis J. Salamone Denis J. SalamoneFebruary 22, 2023
/s/ John R. Scannell John R. ScannellFebruary 22, 2023
/s/ Rudina Seseri Rudina SeseriFebruary 22, 2023
/s/ Kirk W. Walters Kirk W. WaltersFebruary 22, 2023
/s/ Herbert L. Washington Herbert L. WashingtonFebruary 22, 2023

Previous: Item 15. Exhibits and Financial Statement Schedules.